Dihydroberberine
TL;DR
A hydrogenated berberine derivative absorbed roughly 5x better than berberine, converted back to berberine in the gut; promising for blood sugar with early human data but a much thinner evidence base than its parent compound.
Ideal For
- People who get GI side effects from standard berberine
- Those wanting berberine-level effects at lower pill burden
- Users of glucose-disposal supplements around high-carb meals
Avoid If
- You are pregnant or breastfeeding
- You take cyclosporine, metformin, or CYP-metabolized drugs without medical guidance
- You want the deep RCT track record (standard berberine has it)
Frequently Asked Questions
Overview
Dihydroberberine (DHB) is berberine that has been chemically reduced, a trick borrowed from gut microbiology: intestinal bacteria convert berberine to dihydroberberine for absorption, then it re-oxidizes back to berberine in the bloodstream. Supplementing DHB directly bypasses this bottleneck. A pharmacokinetic study found DHB achieves about 5x the plasma berberine AUC of an equal berberine dose, allowing lower doses (100-200 mg vs 500 mg) with less GI distress. However, the decades of berberine RCTs on glucose and lipids do not automatically transfer; DHB-specific human outcome trials are still sparse. It is a reasonable berberine alternative, not a proven upgrade.
How It Works
- Absorbed as DHB then re-oxidized to berberine in plasma, achieving ~5x higher exposure
- Activates AMPK, improving insulin sensitivity and glucose uptake
- May lower LDL via upregulated LDL-receptor expression (berberine mechanism)
- Lower required dose reduces the GI side effects common with 500 mg berberine
Health Concerns Addressed
No linked health concerns yet.
Supporting Research10 studies
Berberine and health outcomes: An umbrella review
This review aimed to summarize and to grade the available evidence on the association between berberine consumption and health-related outcomes.
Berberine and health outcomes: An umbrella review
Li Z, Wang Y, Xu Q +2 more
This review aimed to summarize and to grade the available evidence on the association between berberine consumption and health-related outcomes.
Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial
Moon JM, Ratliff KM, Hagele AM +3 more
Dihydroberberine produced substantially higher and faster plasma berberine appearance than an equivalent berberine dose.
Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
Xie W, Su F, Wang G +2 more
the glucose-lowering effects of berberine are only under hyperglycemic conditions or in a high-glucose-dependent manner
Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
the glucose-lowering effects of berberine are only under hyperglycemic conditions or in a high-glucose-dependent manner
The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Guo J, Chen H, Zhang X +4 more
Berberine significantly reduced fasting plasma glucose, HbA1c, HOMA-IR, LDL and triglycerides versus control.
Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials
Liu D, Zhao H, Zhang Y +2 more
The results indicate that berberine significantly reduces triglycerides (TG) (WMD: -0.367 mmol/L; 95% CI: -0.560 to -0.175; p < 0.001)
Differences in Metabolite Profiles of Dihydroberberine and Micellar Berberine in Caco-2 Cells and Humans - A Pilot Study
Kwon M, Roh YS, Kuo YC
Dihydroberberine yielded higher berberine and reduced-metabolite concentrations than micellar berberine.
Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Ju J, Li J, Lin Q +1 more
Sixteen trials with total of 2147 participants were judged to be eligible and were included in the meta-analysis.
Efficacy of berberine in patients with type 2 diabetes mellitus
Yin J, Xing H, Ye J
The hypoglycemic effect of berberine was similar to that of metformin.
Safety Information
Potential Side Effects
Better tolerated than berberine; occasional mild GI upset. Hypoglycemia risk when combined with diabetes medication.
Drug Interactions
- metformin
- cyclosporine
- CYP3A4 substrates
- antihypertensives
Pregnancy & Breastfeeding
Pregnancy: likely_unsafe
Breastfeeding: likely_unsafe
Dosage Guidelines
Dosage Used in Studies
Consult healthcare provider
Forms Compared
Food & Timing
With meals, particularly carbohydrate-containing ones
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.